For your patients
This column describes initiatives for improving oncologic outcomes by implementing recommendations outlined in the Operative Standards for Cancer Surgery manual.
Clinical Trial Examines Postoperative Chemotherapy versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
The S2104 trial compares chemotherapy to observation following resection of pancreatic neuroendocrine tumors.
General surgeons offer continuity of care for surgical diseases and provide expertise on general surgery conditions, which helps provide safe and effective care for cancer patients.
Describes the results of clinical trials using ctDNA to improve survival for patients at high risk of cancer recurrence.
Describes the benefits of synoptic reporting, specifically its ability to automate data capture, promote interoperability, and increase research opportunities.
More in this category
- Tailoring systemic therapy for HER2+ early breast cancer—The CompassHER2 Trials
- Improving patient-centered breast cancer treatment decisions
- Role of radiation in the treatment of pancreatic adenocarcinoma in the neoadjuvant setting
- Tips and strategies to maximize the use and impact of social media
- Surgical oncology for the general surgeon
- Using the palliative performance scale to increase goals of care conversations
- Surgical emergencies in advanced cancer patients: How to navigate a perilous time
- Reducing duration of postoperative prophylactic antibiotics in neonatal surgery
- Clinical trial for patients with incidentally discovered T2 or T3 gallbladder cancer: OPT-IN/EA2197
- Reducing returns to the operating room
- Neoadjuvant immunotherapy: Results in melanoma show promise and pave the way for other solid tumors
- Australian hospital calls in the COPS to improve care of older patients
- Trials explore whether endocrine therapy can delay or avert surgery in low-risk DCIS
- Hospital aims to stop the clot in neurosurgery
- Preoperative radiotherapy for retroperitoneal sarcoma: Where do we go from here?